Efficacy and safety of biologic agents for IgA nephropathy: A protocol for systematic review and meta-analysis.
Ma Jia, Xing Jianyue, Zhang Yupeng, +1 more·PloS one
BACKGROUND: IgA nephropathy (IgAN) is the most prevalent primary glomerulonephritis worldwide and a leading cause of chronic kidney failure. There are currently no definitive therapeutic regimens to treat or prevent the progression of IgAN. However, biologic agents offer novel therapeutic approaches that target immunol…